Trexquant Investment’s Acadia Pharmaceuticals ACAD Stock Holding History

Trexquant Investment’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.25M	Sell	235,946 -61,856	-21%	-$1.48M	0.04%	630
2025 Q4	$7.95M	Buy	297,802 +69,714	+31%	+$1.67M	0.07%	392
2025 Q3	$4.87M	Sell	228,088 -281,861	-55%	-$6.67M	0.05%	558
2025 Q2	$11M	Buy	509,949 +215,652	+73%	+$4.01M	0.12%	217
2025 Q1	$4.89M	Sell	294,297 -138,858	-32%	-$2.52M	0.06%	513
2024 Q4	$7.95M	Buy	433,155 +49,166	+13%	+$794K	0.09%	348
2024 Q3	$5.91M	Buy	383,989 +82,311	+27%	+$1.37M	0.07%	411
2024 Q2	$4.9M	Sell	301,678 -37,833	-11%	-$611K	0.07%	408
2024 Q1	$6.28M	Buy	339,511 +297,367	+706%	+$7.37M	0.13%	232
2023 Q4	$1.32M	Buy	+42,144	New	+$1.01M	0.03%	719
2023 Q3	–	Sell	-157,084	Closed	-$3.76M	–	1412
2023 Q2	$3.76M	Buy	157,084 +47,887	+44%	+$1.06M	0.1%	284
2023 Q1	$2.06M	Buy	109,197 +8,409	+8%	+$160K	0.06%	449
2022 Q4	$1.6M	Buy	100,788 +53,208	+112%	+$832K	0.05%	490
2022 Q3	$778K	Buy	+47,580	New	+$771K	0.03%	625
2022 Q2	–	Sell	-98,612	Closed	-$2.39M	–	1469
2022 Q1	$2.39M	Buy	+98,612	New	+$2.39M	0.11%	219
2021 Q4	–	Sell	-23,902	Closed	-$397K	–	1258
2021 Q3	$397K	Sell	23,902 -15,732	-40%	-$303K	0.03%	630
2021 Q2	$967K	Buy	+39,634	New	+$895K	0.08%	318
2021 Q1	–	Sell	-23,797	Closed	-$1.27M	–	1078
2020 Q4	$1.27M	Buy	23,797 +5,552	+30%	+$276K	0.13%	205
2020 Q3	$753K	Buy	18,245 +3,077	+20%	+$133K	0.05%	521
2020 Q2	$735K	Sell	15,168 -2,528	-14%	-$121K	0.05%	517
2020 Q1	$748K	Sell	17,696 -74,645	-81%	-$3.08M	0.05%	507
2019 Q4	$3.95M	Buy	92,341 +67,844	+277%	+$2.95M	0.23%	137
2019 Q3	$882K	Buy	24,497 +741	+3%	+$22.5K	0.08%	315
2019 Q2	$635K	Sell	23,756 -6,481	-21%	-$166K	0.06%	416
2019 Q1	$812K	Sell	30,237 -10,522	-26%	-$246K	0.06%	451
2018 Q4	$659K	Buy	+40,759	New	+$791K	0.04%	543
2018 Q3	–	Sell	-28,281	Closed	-$432K	–	915
2018 Q2	$432K	Sell	28,281 -23,649	-46%	-$422K	0.03%	581
2018 Q1	$1.17M	Buy	+51,930	New	+$1.44M	0.08%	372